drugset / Trial / NCT02879435
Management of Postoperative Pain With Preemptive Analgesia in Cesarean Section
RandomizedSingle-groupTriple-blindTreatment
Summary
This research will explore the question of whether preincisional skin infiltration with bupivacaine 0.25% decreases postoperative pain after Cesarean delivery.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-12
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Subcutaneous |
| Subject | Bupivacaine | Other / unclassified | 10 ml | Subcutaneous |
Indications
No indication recorded.